The Effect of Virtual Reality Based Relaxation Program on Patients to be Performed Bronchoscopy
The Effect of Virtual Reality-Based Relaxation Program on Pain Severity, Anxiety Level and Patient Satisfaction in Patients to be Performed Bronchoscopy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Gülcan B Turan
- Phone Number: 05065576086
- Email: glcnbah@hotmail.com
Study Contact Backup
- Name: Ayşegül B Akiç
- Phone Number: +90 538 824 30 32
- Email: a_akic123@hotmail.com
Study Locations
-
-
Center
-
Elazığ, Center, Turkey, 25240
- Fırat University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- be18 years and over
- Ability to communicate adequately
- Absence of psychiatric problems
- Those who are determined by the physician that they do not have a physical disability in exercising
- Volunteering to participate in the research
- Individuals who have the ability to use technological tools
- Patients who underwent local application in bronchoscopy
Exclusion Criteria:
- Those who have communication problems
- Those with psychiatric problems
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental:
Bronchoscopy of Virtual Reality Based Relaxation Program Will Be Applied
|
Virtual Reality Based Relaxation Program
|
|
No Intervention: No Intervention
Bronchoscopy of Virtual Reality Based Relaxation Program Will Not Be Applied
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale Evaluation
Time Frame: 60 minutes
|
Visual Analog Scale is used to convert some values that cannot be measured numerically into digital.
Two end definitions of the parameter to be evaluated are written at the two ends of a 100 mm line and the patient is asked to indicate where on this line their situation is appropriate by drawing a line or by placing a dot or pointing.0
points means no pain, 100 points means a lot of pain
|
60 minutes
|
|
Virtual Reality Glasses Application Satisfaction Form
Time Frame: 60 minutes
|
In this form, there are questions prepared in line with the relevant literature (Dutucu, 2019) in order to determine the satisfaction with the video watched with virtual reality glasses.The higher the score, the higher the satisfaction
|
60 minutes
|
|
Anxiety Assessment Scale
Time Frame: 60 minutes
|
Patients will be asked to show their anxiety levels before and after the procedure on a 10 cm long horizontal line.
Line has 0 at the beginning and 10 at the end.
10 means very extreme anxiety and 0 means no anxiety.
|
60 minutes
|
|
Physiological Symptoms of Anxiety Follow-up Form
Time Frame: 60 minutes
|
This form was created by the researcher to record blood pressure, heart rate, respiratory rate and peripheral oxygen saturation value.These values will be checked again in 4 weeks.
|
60 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Gülcan B Turan, Firat University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- E-97132852-050.01.04-87889
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.